Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon in AIDS.

S E Krown1, F X Real, S Vadhan-Raj

  • 1Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

Journal of Experimental Pathology
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2021
Same author

Pancreatic cancer transcriptomes: molecular stratification in the adjuvant setting.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives.

International journal of epidemiology·2018
Same author

A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models.

BMC cancer·2016
Same author

SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150.

Oncogene·2015

Interferon (IFN) production issues may explain AIDS immunologic problems. Certain IFNs show potential for treating Kaposi

Area of Science:

  • Immunology
  • Virology
  • Oncology

Background:

  • Interferons (IFNs) are natural proteins with crucial regulatory functions.
  • Acquired immunodeficiency syndrome (AIDS) is characterized by immunologic abnormalities and disease susceptibilities.
  • Systemic symptoms in AIDS may be linked to excessive production of unusual interferon types.

Purpose of the Study:

  • To explore the role of interferons in the immunologic abnormalities of AIDS.
  • To investigate the potential therapeutic applications of interferons in managing AIDS complications.
  • To examine the unexplored roles of alpha and gamma interferons in treating HTLV-III/LAV viremia and secondary infections.

Main Methods:

  • This study is a review of existing literature and research on interferons and AIDS.

Related Experiment Videos

  • Analysis of the impact of impaired and excessive interferon production on AIDS pathogenesis.
  • Evaluation of the potential efficacy of alpha and gamma interferons in therapeutic contexts.

    • Main Results:

    • Impaired interferon production correlates with immunologic dysfunction and increased susceptibility to infections in AIDS patients.
    • Excessive production of specific interferon types may contribute to systemic symptoms observed in AIDS.
    • Alpha interferons demonstrate therapeutic potential against Kaposi's sarcoma, a major AIDS complication.
    • Both alpha and gamma interferons show promise for treating Human T-lymphotropic virus type III/Lymphadenopathy-associated virus (HTLV-III/LAV) viremia.

    Conclusions:

    • Interferon dysregulation plays a significant role in AIDS pathogenesis and clinical manifestations.
    • Alpha and gamma interferons offer potential therapeutic avenues for managing AIDS, including viremia, Kaposi's sarcoma, and secondary infections.